The China Radiopharmaceuticals Market analysis highlights a transformative era for nuclear medicine in the country, catalyzed by the "Mid- and Long-Term Development Plan (2021–2035) for Medical Isotopes." This state-backed initiative is designed to reduce China's historical reliance on imported radioisotopes by establishing a domestic, independent supply chain. As the prevalence of cancer...